[Treatment and prognosis of juvenile retinal detachment].
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to S Okinami.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Epstein-Barr virus-related antibody titers were determined in 30 patients with anterior uveitis, 45 with pan-uveitis, including 19 with Behçet's disease, 11 with Vogt-Koyanagi-Harada's disease and 15 with unclassified pan-uveitis, and 144 age-matched healthy controls. The frequencies of anti-VCA (viro-capsid antigen) and anti-EA (early antigen) in uveitis patients and in controls were similar, but the frequency of sera with elevated titers (greater than or equal to 1:160) and the geometric mean titer of anti-VCA in the patients with anterior uveitis was significantly higher than in the controls (P less than 0.025, P less than 0.01) and in the patients with pan-uveitis (P less than 0.001). The frequency of sera with elevated titers of anti-EBNA (Epstein-Barr virus associated nuclear antigen) (greater than or equal to 1:160) in the patients with pan-uveitis was significantly lower than in the controls (P less than 0.02) and in the patients with anterior uveitis (P less than 0.01). Among the patients with pan-uveitis, there was no significant difference in the pattern of antibodies. These data are compatible with the interpretation that there may be both anatomical and immunological differences between anterior and pan-uveitis.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.